Medicare Enrolled
Dr. Christopher Ruisi, M.D.
Cardiovascular Disease · Jacksonville, FL
Practice pattern: Electrophysiology & Remote— Practice combining electrophysiology and remote services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ruisi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ruisi? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ruisi
Dr. Christopher Ruisi is a cardiovascular disease in Jacksonville, FL, with 19 years in practice. Based on federal Medicare data, Dr. Ruisi performed 6,105 Medicare services across 4,217 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ruisi received a total of $19,959 from 41 pharmaceutical and/or device companies across 376 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ruisi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 16% volume in FL$ $19,959 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,105
Medicare services
Top 16% in FL for cardiovascular disease
4,217
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~321 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead | 1,283 | $11 | $69 |
| Office visit, established patient (30-39 min) | 1,224 | $91 | $320 |
| Remote pacemaker monitoring, 90 days | 817 | $23 | $77 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 771 | $19 | $68 |
| Hospital follow-up visit, moderate complexity | 243 | $63 | $179 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 210 | $26 | $115 |
| EKG interpretation and report | 148 | $6 | $23 |
| New patient office visit (45-59 min) | 140 | $123 | $423 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 122 | $16 | $63 |
| Programming of dual lead pacemaker system | 112 | $58 | $204 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 89 | $17 | $68 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 88 | $40 | $145 |
| Office visit, established patient (20-29 min) | 82 | $61 | $228 |
| Initial hospital admission, moderate complexity | 65 | $101 | $341 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 56 | $17 | $66 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 52 | $16 | $62 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 44 | $2 | $8 |
| Ultrasound of heart blood flow, valves and chambers | 43 | $14 | $45 |
| Interpretation and report of ultrasound of heart | 39 | $70 | $232 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 37 | $767 | $2,971 |
| Evaluation of cardiac rhythm monitor system | 36 | $36 | $127 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 31 | $13 | $47 |
| Initial hospital admission, high complexity | 31 | $137 | $499 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 30 | $52 | $186 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 29 | $361 | $1,378 |
| Programming of heart rhythm stimulation after drug infusion | 28 | $64 | $844 |
| Telephone medical discussion with physician, 5-10 minutes | 26 | $42 | $140 |
| Insertion of heart rhythm monitor under skin | 25 | $62 | $5,509 |
| Programming of multiple lead implantable defibrillator system | 22 | $78 | $270 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 21 | $255 | $828 |
| Anticoagulant management of patient taking warfarin | 21 | $8 | $29 |
| Hospital discharge day management, 30 minutes or less | 21 | $64 | $180 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 19 | $385 | $1,247 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 18 | $255 | $827 |
| Insertion of implantable defibrillator system | 16 | $705 | $2,433 |
| Removal of heart rhythm monitor from under the skin | 15 | $39 | $347 |
| Programming of multiple lead pacemaker system | 13 | $65 | $216 |
| Programming of dual lead implantable defibrillator system | 13 | $71 | $251 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 13 | $58 | $680 |
| Office visit, established patient (10-19 min) | 12 | $40 | $142 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
25.3% high complexity
0.9% medium
73.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$19,959
Total received (2018-2024)
Avg $2,851/year across 7 years
Top 14% in FL for cardiovascular disease
41
Companies
376
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,884 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$76 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,509
2023$5,440
2022$2,368
2021$1,077
2020$697
2019$3,120
2018$4,749
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medical Device Business Services, Inc.
$4,773
Biosense Webster, Inc.
$2,665
Boston Scientific Corporation
$2,587
BIOTRONIK INC.
$1,722
Medtronic, Inc.
$1,596
Abbott Laboratories
$1,514
Medtronic Vascular, Inc.
$841
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$726
PFIZER INC.
$530
Novartis Pharmaceuticals Corporation
$304
Janssen Pharmaceuticals, Inc
$251
SANOFI-AVENTIS U.S. LLC
$231
Baxter Healthcare
$224
Amgen Inc.
$201
iRhythm Technologies, Inc.
$175
E.R. Squibb & Sons, L.L.C.
$172
BOSTON SCIENTIFIC CORPORATION
$166
ATRICURE, INC.
$143
CVRx, Inc.
$119
Acutus Medical, Inc.
$103
Aziyo Biologics, Inc.
$97
Boehringer Ingelheim Pharmaceuticals, Inc.
$85
AstraZeneca Pharmaceuticals LP
$77
Merck Sharp & Dohme LLC
$75
Stereotaxis Inc
$65
ABIOMED
$64
Braemar Manufacturing, LLC
$58
Edwards Lifesciences Corporation
$55
Impulse Dynamics (USA) Inc.
$41
Alnylam Pharmaceuticals Inc.
$39
Merck Sharp & Dohme Corporation
$37
Philips North America LLC
$34
AtriCure, Inc.
$32
GENZYME CORPORATION
$30
Actelion Pharmaceuticals US, Inc.
$26
Philips Electronics North America Corporation
$20
Amarin Pharma Inc.
$19
Gilead Sciences, Inc.
$19
Novo Nordisk Inc
$18
Ethicon US, LLC
$14
Kowa Pharmaceuticals America, Inc.
$12
Top 3 companies account for 50.2% of total payments
Associated products mentioned in payments ›
(5044) MCOT · (CK4) MCOT · ACHIEVE · ADAPTA · ADVISA DR MRI SURESCAN · AMPLIA MRI QUAD CRT-D SURESCAN · AMVUTTRA · ARCTIC FRONT ADVANCE · ASSURITY · AVEIR · AZURE XT DR MRI SURESCAN · Acticor 7 VR-T DX · Allure Quadra RF CRT Pacemaker · Amplia MRI · Aortic and Mitral Tissue Stented Valves · Arctic Front · AtriCure Synergy Ablation System · Azure · Barostim Neo System · CAMZYOS · CARTO 3 · CHANTIX · COBALT DR MRI SURESCAN · COMPIA MRI QUAD CRT-D SURESCAN · CapSure Sense · CapSureFix · Capsure · Cardiac Monitoring Suite · CardioInsight · Carto 3 · Carto 3 System · Carto Smarttouch · CartoSound · Confirm Rx · Corlanor · ECM Patch · ELIQUIS · EMBLEM MRI S-ICD · ENSITE PRECISION · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edora 8 DR-T · Ellipse ICD · EnSite Precision Cardiac Mapping System · Ensite Cardiac Mapping System · FARXIGA · FORTIFY ASSURA · Fortify Assura · GENERAL BRADY · GENERAL THERAPIES · GENERAL TACHY · General - Therapies · HemoSphere · Hillrom - Cardiac Ambulatory Monitor · Hillrom - Carnation Ambulatory Monitor · Impella · JARDIANCE · LABSYSTEM · LEQVIO · LINQ II · LifeVest · Livalo · MICRA · MULTAQ · Micra · MyCareLink · NA · Niobe · ONPATTRO · OPSUMIT · Optimizer · Ozempic · PERCLOT · PRADAXA · PRALUENT · PULSESELECT · Pouch · QDOT MICRO Catheter · Quartet CRT Lead · RESONATE · RESONATE EL ICD VR · RHYTHMIA · Repatha · Reveal LINQ · Rhythmia Mapping System · Rivacor · Rivacor 7 DR-T · S-ICD System Magnet · STARCLOSE SE · STRATAFIX · Selectra · SensiTherm (ICE) · THERMOCOOL SMARTTOUCH · TYRX · Trifecta Tissue Heart Valve · VERQUVO · VYNDAQEL · Vascepa · VersaCross Access Solution · WATCHMAN FLX · XARELTO · ZIO XT Patch · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $327 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
154
Per 100K population
15.3
County median income
$68,447
Nearest hospital
BAPTIST HEALTH MEDICAL CENTER - JACKSONVILLE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ruisi is a electrophysiology & remote specialist, with above-average Medicare volume (top 16% in FL), and high industry engagement (low-engagement, top 14%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ruisi experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Ruisi performed 1,283 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ruisi receive payments from pharmaceutical companies?
Yes. Dr. Ruisi received a total of $19,959 from 41 companies across 376 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ruisi's costs compare to other cardiovascular diseases in Jacksonville?
Dr. Ruisi's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ruisi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Jacksonville
Browse cardiovascular diseases in Jacksonville ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in FL
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in FL
Which FL cardiovascular diseases receive the most from drug and device companies.
By company
Medical Device Business Services, Inc. Payments to Doctors
See all physicians who received payments from Medical Device Business Services, Inc..
By company
Biosense Webster, Inc. Payments to Doctors
See all physicians who received payments from Biosense Webster, Inc..
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology